Senate Finance Committee Chairman Chuck Grassley (R-Iowa), along with Ranking Member Ron Wyden (D-Ore.) and Sens. Todd Young (R-Ind.) and Ben Cardin (D-Md.), sent a letter to the Department of Health and Human Services (HHS) concerning their oversight procedures for the organ procurement and transplantation system in the United States. This probe comes after numerous inspector general audits and news reports raised questions about the adequacy of patient safety standards, suggested thousands of available organs are not being used and highlighted questionable financial practices of some organ procurement organizations (OPOs).
“The Department’s own data suggests that thousands of lifesaving organs go unrecovered every year, and investigative reporting has highlighted significant lapses in quality control and patient safety, including a report last month about a patient who died after the organ procurement organization (OPO) responsible for the transplant incorrectly identified the donor’s blood type,” the senators wrote.
“Our concerns regarding the Department’s role in overseeing our nation’s organ procurement organizations (OPOs) stem from Inspector General audits/reports, whistleblower accounts, investigative reporting, and research. Additionally, our internal analysis has shed light on the gaps in the federal government’s oversight, resulting in fraud, waste, and abuse of our nation’s Medicare program and American taxpayer dollars.”
This letter is part of the ongoing Finance committee investigation into the conduct of the nation’s organ donation and procurement system. In February, the members sent an expansive request for information and data to the United Network for Organ Sharing (UNOS), which was contracted by Congress nearly four decades ago to oversee the U.S. Organ Procurement and Transplantation Network (OPTN). The response from UNOS can be found HERE.
Full text of the letter to HHS Secretary Alex Azar can be found HERE